Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective

INTRODUCTION: Studies that estimate the economic burden of pediatric pneumococcal disease often only report direct medical costs and omit indirect non-medical costs. Given these indirect costs are not included in most calculations, the full economic burden attributable to pneumococcal conjugate vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiuyan, Warren, Sophie, Rozenbaum, Mark H., Perdrizet, Johnna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017895/
https://www.ncbi.nlm.nih.gov/pubmed/36867396
http://dx.doi.org/10.1007/s40121-023-00780-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017895/
https://www.ncbi.nlm.nih.gov/pubmed/36867396
http://dx.doi.org/10.1007/s40121-023-00780-7

Ejemplares similares